The JLABS CEO Summit 2025, held on June 24–25, 2025, at the historic Rijksmuseum Boerhaave in Leiden, The Netherlands, brought together Johnson & Johnson leaders, investors, and startup executives from across Europe. This annual flagship event serves as a platform for open exchange between the JLABS community and the broader innovation ecosystem.
The two-day summit focused on key themes shaping the future of biotechnology and healthcare — from early-stage R&D and regulatory navigation to financing strategies and clinical translation.
Robert Aleksandrowicz, CEO of Cellis, joined the meeting as a panelist, contributing insights from the company’s experience in developing macrophage-based therapies and navigating the path from research to clinical development.
We thank Johnson & Johnson Innovation – JLABS for creating such a collaborative and forward-looking environment, and for recognizing the value of connecting science-driven companies that are transforming the landscape of modern medicine.
